Phase I trial of a patch-based influenza vaccine.
Phase of Trial: Phase I
Latest Information Update: 11 Dec 2017
At a glance
- Drugs Influenza virus vaccine (Primary) ; Heat-labile enterotoxin E coli
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Intercell USA; Valneva USA
- 11 Dec 2017 According to a Valneva media release, Intercell USA changed its name to Valneva USA.
- 15 Nov 2012 Status changed from active, no longer recruiting to completed.
- 25 May 2007 Status change from inititated to in progress; interim results reported.